GCNT1 and neoplasm: Although the other MYCN-amplified tumor sample NB2 showed low transcription levels of C2GNT1, we observed remarkable high levels of most of the downstream glycosyltransferases evaluated, suggesting a presumed high expression of Lewis glycans.